TI
BIO icon

Tidal Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Tidal Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Sell
2,878
-240
-8% -$68.1K ﹤0.01% 1829
2026
Q1 		$869K Buy
3,118
+1,731
+125% +$499K ﹤0.01% 1549
2025
Q4 		$420K Sell
1,387
-1,982
-59% -$618K ﹤0.01% 1726
2025
Q3 		$945K Sell
3,369
-277
-8% -$75.4K ﹤0.01% 1243
2025
Q2 		$880K Sell
3,646
-16
-0.4% -$3.78K 0.01% 1103
2025
Q1 		$892K Buy
3,662
+2,593
+243% +$780K 0.01% 1020
2024
Q4 		$351K Buy
1,069
+186
+21% +$63.1K ﹤0.01% 1536
2024
Q3 		$295K Sell
883
-2,077
-70% -$660K ﹤0.01% 1606
2024
Q2 		$808K Sell
2,960
-690
-19% -$201K 0.01% 1015
2024
Q1 		$1.26M Buy
3,650
+367
+11% +$121K 0.02% 772
2023
Q4 		$1.06M Buy
3,283
+1,221
+59% +$383K 0.02% 601
2023
Q3 		$739K Buy
2,062
+1,459
+242% +$563K 0.02% 654
2023
Q2 		$229K Sell
603
-1,349
-69% -$549K 0.01% 1155
2023
Q1 		$935K Buy
1,952
+586
+43% +$274K 0.03% 521
2022
Q4 		$574K Buy
1,366
+10
+0.7% +$4.04K 0.02% 622
2022
Q3 		$566K Buy
1,356
+31
+2% +$15.5K 0.02% 529
2022
Q2 		$656K Buy
1,325
+123
+10% +$64.1K 0.02% 509
2022
Q1 		$677K Sell
1,202
-77
-6% -$46.4K 0.02% 559
2021
Q4 		$966K Buy
1,279
+125
+11% +$93.5K 0.03% 418
2021
Q3 		$863K Buy
1,154
+693
+150% +$519K 0.03% 371
2021
Q2 		$297K Buy
+461
New +$281K 0.01% 576

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Tidal Investments's BIO Position: Q2 2026 in Review

Tidal Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 7.7% in Q2 2026, selling an estimated $68.1K and leaving 2,878 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Tidal Investments first reported a position in BIO in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.26M in Q1 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Tidal Investments held 2,878 shares of Bio-Rad Laboratories Class A worth $845K as of Q2 2026.
  • Tidal Investments sold 240 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $68.1K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1829 holding.
  • Tidal Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and has held it in 21 quarters since.
  • Tidal Investments's Bio-Rad Laboratories Class A position peaked at $1.26M in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.